Loading...
CurveBeam AI Community
ASX:CVB Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
Community Investing Ideas
FDA Clearance And AI Advances Will Unlock Future Markets
Key Takeaways Regulatory advancements, AI-driven workflow enhancements, and vendor financing are set to drive revenue growth and expand CurveBeam AI's market reach in healthcare imaging. Diversification across products, applications, geographies, and customer segments decreases risk and supports stable, recurring revenue as orthopedic imaging demand rises.Read more
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AU$0.15
53.3% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
52.26% p.a.
Profit Margin
15.46%
Future PE
11.23x
Price in 2028
AU$0.19
